Phone: +1 (888) 98-EMERY
Phone: +1 (510) 899-8814
[email protected]
Home
Corporate
About
Management Team
Testimonials
FAQ
Collaborators
We’re Hiring
Cell & Microbiology
Minimum Inhibitory (MIC) and Minimal Bactericidal (MBC) Concentration Testing
Time-Kill Kinetics Assay – Antimicrobial Efficacy Test
Biofilm Eradication Testing
Antibiotic Resistance Testing
Cytotoxicity Testing
Antimicrobial Synergy Study – Checkerboard Testing
Microorganism Inventory
Bacteria Inventory
Fungi Inventory
Viruses Inventory
Chemistry
Nuclear Magnetic Resonance (NMR) Spectroscopy
Liquid Chromatography – Mass Spectrometry (LC-MS)
Bioanalytical Services and HPLC Method Development
Medicinal Chemistry Support
Gas Chromatography (GC)
Deuterated Reference Standards
Litigation Support
Media
Resources
News
Blog
Videos
Newsletter
Contact Us
No menu assigned!
Dr. Eshani Nandita of Emery Pharma shares the results of the stability study of Ranitidine
0
Shares
Share
0
0
Previous Project
Next Project
Home
Corporate
About
Management Team
Testimonials
FAQ
Collaborators
We’re Hiring
Cell & Microbiology
Minimum Inhibitory (MIC) and Minimal Bactericidal (MBC) Concentration Testing
Time-Kill Kinetics Assay – Antimicrobial Efficacy Test
Biofilm Eradication Testing
Antibiotic Resistance Testing
Cytotoxicity Testing
Antimicrobial Synergy Study – Checkerboard Testing
Microorganism Inventory
Bacteria Inventory
Fungi Inventory
Viruses Inventory
Chemistry
Nuclear Magnetic Resonance (NMR) Spectroscopy
Liquid Chromatography – Mass Spectrometry (LC-MS)
Bioanalytical Services and HPLC Method Development
Medicinal Chemistry Support
Gas Chromatography (GC)
Deuterated Reference Standards
Litigation Support
Media
Resources
News
Blog
Videos
Newsletter
Contact Us